# A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

> **NCT02495246** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 32 (actual)

## Conditions studied

- Ebola Virus Disease

## Interventions

- **BIOLOGICAL:** ChAd3-EBO-Z
- **BIOLOGICAL:** Ad26.ZEBOV

## Key facts

- **NCT ID:** NCT02495246
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-21
- **Primary completion:** 2017-08-22
- **Final completion:** 2017-08-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02495246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02495246, "A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02495246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*